MESOBLAST UK LIMITED

Active London

Non-trading company

0 employees website.com
Non-trading company
M

MESOBLAST UK LIMITED

Non-trading company

Founded 7 Apr 2011 Active London, United Kingdom 0 employees website.com
Non-trading company
Accounts Submitted 12 Feb 2026 Next due 31 Mar 2027 10 months remaining
Confirmation Submitted 1 May 2025 Next due 21 Apr 2026 2 months overdue
Net assets £282M £24M 2025 year on year
Total assets £283M £24M 2025 year on year
Total Liabilities £736K £93K 2025 year on year
Charges 7
4 outstanding 3 satisfied

Contact & Details

Contact

Registered Address

5 New Street Square London EC4A 3TW

Full company profile for MESOBLAST UK LIMITED (07596260), an active company based in London, United Kingdom. Incorporated 7 Apr 2011. Non-trading company. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jul → 30 Jun 2025
Type full
Next accounts 30 Jun 2026
Due by 31 Mar 2027 10 months remaining

Balance Sheet & P&L (2014–2025)

Cash in Bank

N/A

Net Assets

£282.16M

Decreased by £24.06M (-8%)

Total Liabilities

£736.21k

Increased by £92.98k (+14%)

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2025
30 Jun Year End
2024
30 Jun Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 176,729,000 Shares £176.73m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
30 Jun 202450,000,000$50.00m$1
30 Jun 202352,729,000$52.73m$1
30 Jun 202152,000,000$52.00m$1
29 Jun 202022,000,000$22.00m$1

Officers

Officers

1 active 2 resigned
Status
Michael Anthony SampsonDirectorBritishUnited Kingdom744 May 2016Active

Shareholders

Shareholders (2)

Mesoblast Limited
100.0%
389,362,990
Mesoblast Limited
0.0%
1

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Mesoblast Limited

Australia

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

MESOBLAST UK LIMITED Current Company

Charges

Charges

4 outstanding 3 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
12 Feb 2026AccountsAnnual accounts made up to 30 Jun 2025
1 May 2025Confirmation StatementConfirmation statement made on 7 Apr 2025 with updates
17 Mar 2025AccountsAnnual accounts made up to 30 Jun 2024
20 Dec 2024AccountsAnnual accounts made up to 30 Jun 2024
1 Jul 2024CapitalAllotment of shares (GBP 1) on 30 Jun 2024
12 Feb 2026 Accounts

Annual accounts made up to 30 Jun 2025

1 May 2025 Confirmation Statement

Confirmation statement made on 7 Apr 2025 with updates

17 Mar 2025 Accounts

Annual accounts made up to 30 Jun 2024

20 Dec 2024 Accounts

Annual accounts made up to 30 Jun 2024

1 Jul 2024 Capital

Allotment of shares (GBP 1) on 30 Jun 2024

Recent Activity

Latest Activity

Annual accounts made up to 30 Jun 2025

3 months ago on 12 Feb 2026

Confirmation statement made on 7 Apr 2025 with updates

1 years ago on 1 May 2025

Annual accounts made up to 30 Jun 2024

1 years ago on 17 Mar 2025

Annual accounts made up to 30 Jun 2024

1 years ago on 20 Dec 2024

Allotment of shares (GBP 1) on 30 Jun 2024

1 years ago on 1 Jul 2024